CTVA vs SMG: Corteva and Scotts Miracle-Gro compared
The short version
From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.
- Corteva is the larger company, worth $8.7B, about 3.0 times Scotts Miracle-Gro.
- Scotts Miracle-Gro grew revenue faster over the last year (+1.1% vs -1.2%).
- On earnings, Corteva is the cheaper stock (7.1x vs 14.2x).
- Scotts Miracle-Gro's price assumes faster free cash flow growth: about -4% a year, against -22% for Corteva (reverse DCF).
Side by side
The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.
| Measure | CTVA | SMG |
|---|---|---|
| Market cap | $8.7B | $2.9B |
| Share price | $13.24 | $49.86 |
| Revenue (last fiscal year) | $17.4B | $3.4B |
| Free cash flow (last fiscal year) | $2.8B | $274M |
| Revenue growth, last year | -1.2% | +1.1% |
| Revenue growth per year, last 5 fiscal years | +2.7% | -8.8% |
| Operating margin | — | 11.0% |
| Net margin | 5.7% | 2.1% |
| Return on equity | 4.0% | — |
| P/E (trailing) | 7.06x | 14.2x |
| Price / free cash flow | 3.10x | 10.5x |
| EV / EBITDA | 3.13x | 12.0x |
| FCF growth the price implies | -21.6% | -3.5% |
| Dividend yield | 5.4% | 5.5% |
| Debt / equity | 0.65x | — |
| Fundamental grade | C | D |
| Superinvestors holding it | 8 | 7 |
| Insider purchases, last 12 months | 2 | 1 |
Results from SEC filings
Revenue and free cash flow by fiscal year, from each company's 10-K filings.
Corteva
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $15.7B | $2.2B | — |
| 2022 | $17.5B | $267M | — |
| 2023 | $17.2B | $1.2B | — |
| 2024 | $16.9B | $1.5B | — |
| 2025 | $17.4B | $2.8B | — |
Scotts Miracle-Gro
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $4.9B | $165M | 14.7% |
| 2022 | $3.9B | -$242M | -11.1% |
| 2023 | $3.6B | $438M | -4.9% |
| 2024 | $3.6B | $584M | 5.9% |
| 2025 | $3.4B | $274M | 10.5% |
Where the revenue comes from
Corteva · by segments, 2025
Seed$9.9B57%
Crop Protection$7.5B43%
Scotts Miracle-Gro · by segments, 2025
Reportable segment total$3.2B93%
Other non-reportable operating segment$254M7%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open CTVA in InvestinglyQuestions
Which is bigger, Corteva or Scotts Miracle-Gro?
Corteva (CTVA), at $8.7B against $2.9B.
Is CTVA or SMG cheaper?
By trailing P/E, Corteva (7.06x) is cheaper than Scotts Miracle-Gro (14.2x). A lower multiple can also mean the market expects less growth.
Which grows faster, CTVA or SMG?
Scotts Miracle-Gro: revenue grew +1.1% over the last year, against -1.2%.
Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.